Abstract

Multidisciplinary team (MDT) model in cancer care was introduced and endorsed to ensure that care delivery is consistent with the best available evidence. Over the last few years, regular MDT meetings have become a standard practice in oncology and gained the status of the key decision-making forum for patient management. Despite the fact that cancer MDT meetings are well accepted by clinicians, concerns are raised over the paucity of good-quality evidence on their overall impact. There are also concerns over lack of the appropriate support for this important but overburdened decision-making platform. The growing acceptance by clinical community of the health information technology in recent years has created new opportunities and possibilities of using advanced clinical decision support (CDS) systems to realise full potential of cancer MDT meetings. In this paper, we present targeted summary of the available evidence on the impact of cancer MDT meetings, discuss the reported challenges, and explore the role that a CDS technology could play in addressing some of these challenges.

Highlights

  • Background of MDT Meetings in CancerManagementMultidisciplinary team meetings are known as tumour boards, multidisciplinary cancer conferences, multidisciplinary case reviews, or multidisciplinary clinics, in different health care systems

  • We present targeted summary of the available evidence on the impact of cancer MDT meetings, discuss the reported challenges, and explore the role that a clinical decision support (CDS) technology could play in addressing some of these challenges

  • These different terms may represent the variations in the organisational structure, membership, approach, focus, and the decision processes of these meetings [1]; they all provide a forum for multidisciplinary cancer teams to regularly convene and discuss the diagnostic and treatment aspects of patient care

Read more

Summary

Background of MDT Meetings in Cancer Management

Multidisciplinary team meetings are known as tumour boards, multidisciplinary cancer conferences, multidisciplinary case reviews, or multidisciplinary clinics, in different health care systems. These different terms may represent the variations in the organisational structure, membership, approach, focus, and the decision processes of these meetings [1]; they all provide a forum for multidisciplinary cancer teams to regularly convene and discuss the diagnostic and treatment aspects of patient care. Tumour boards have existed in the United States for the last 50 years [2] Until recently, their primary goal was educational rather than improving patient care. Many other European countries and Australia were quick to adopt the MDT model for cancer care [5, 6]

The Rationale behind Regular MDT Meetings
The Evidence on the Impact of Cancer MDT Meetings
Evidence Summary
Supporting Overburdened MDT Meetings to Realise Their Full Potential
The Potential of Clinical Decision Support Technology in Cancer MDT Meetings
Findings
Concluding Remarks
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.